Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of topical roflumilast 0.3% foam for hidradenitis suppurativa, currently recruitin…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Managed Access Programs for AIN457, Secukinumab
Clinical trial update describing managed access programs for AIN457 (secukinumab) for hidradenitis suppurativa; the program status is AVAILA…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) [Phase 3]
An open-label, single-arm Phase 3 study to evaluate pharmacokinetics and safety of subcutaneous sonelokimab in adolescents with moderate to …
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa [NA]
A clinical trial comparing Nd:YAG laser versus Alexandrite laser treatment for hidradenitis suppurativa; the study status is not yet recruit…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS [Phase 4]
This clinical trial update describes a Phase 4 study comparing topical versus subcutaneous secukinumab for hidradenitis suppurativa, current…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. [Phase 2]
Phase 2 trial evaluating the study medicine Ritlecitinib in adults with hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of SCT650C for moderate to severe hidradenitis suppurativa, with the stud…
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 study of Eltrekibart (LY3041658) in adults with moderate to severe hidradenitis suppurativa. The trial is currently active but not r…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Physical Activity in Hidradenitis Suppurativa (HS) [NA]
A University of Miami-sponsored clinical trial is examining the impact of physical activity on hidradenitis suppurativa and is currently rec…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: 1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa) [Phase 1]
Phase 1 clinical trial evaluating a 1726-nm laser for hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Botulinum Toxin Therapy in Hidradenitis Suppurativa
This clinical trial update reports that a study evaluating botulinum toxin therapy for hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
A prospective cohort study (COVER) enrolling patients with hidradenitis suppurativa, conducted at Nantes University Hospital, currently recr…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
A prospective exploratory biomarker study called SKINERGY sponsored by Leiden University Medical Center is recruiting to profile skin diseas…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Regulation of Inflammatory Genes in Hidradenitis Suppurativa
A University of Alabama at Birmingham clinical trial is investigating regulation of inflammatory genes in hidradenitis suppurativa and is cu…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
Clinical trial update shows recruitment for a study evaluating secukinumab (Cosentyx) for moderate to severe hidradenitis suppurativa. The s…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: HIDRAdenitis Suppurativa and HEART Disease
This ClinicalTrials.gov entry reports an active, not-recruiting trial sponsored by Herlev and Gentofte Hospital investigating hidradenitis s…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients [Phase 1]
Phase I study of QLS12010 capsules evaluating safety, tolerability, pharmacokinetics, pharmacodynamics, and food effects in healthy adults a…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Determinants of Chronic Inflammatory Skin Disease Trajectories
An ongoing clinical study is investigating determinants of chronic inflammatory skin disease trajectories, spanning multiple conditions such…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients [Phase 3]
A Phase 3 clinical trial evaluating an adapted antibiotic regimen for Hurley stage 2 hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-11Clinical Trial Update: Feasibility Study on Radiofrequency-Based Selective Electrothermolysis to Investigate Its Effects on Human Skin [NA]
Johns Hopkins University sponsors a feasibility study evaluating radiofrequency-based selective electrothermolysis on human skin. The trial,…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: An Open-label, Time-lagged, Dose-escalation Study to Evalaute the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa. [EARLY_Phase 1]
An open-label, dose-escalation Phase 1 study is evaluating the safety and efficacy of subcutaneous siplizumab for hidradenitis suppurativa, …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]
A Phase 3 trial evaluating subcutaneous sonelokimab versus placebo for moderate-to-severe hidradenitis suppurativa is currently active but n…
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa [Phase 1, Phase 2]
A Phase 1/2 clinical trial to evaluate the safety, tolerability, efficacy, and pharmacokinetics of LT-002-158 tablets in Chinese adults with…
-
CLINICAL_TRIALS research · 2025-04-16Clinical Trial Update: Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
Ongoing clinical trial evaluating the efficacy and safety of secukinumab in conjunction with surgery for moderate-to-severe hidradenitis sup…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers [Phase 1]
This Phase 1 trial update describes a single- and multiple-ascending dose study of LT-002-158 tablets in healthy adult volunteers, with recr…